(MIR) Miraculum - Ratings and Ratios

Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLKLSTN00017

MIR: Skincare, Fragrances, Haircare, Makeup, Personal Care

Miraculum S.A., established in 1924 and headquartered in Warsaw, Poland, is a longstanding cosmetics company specializing in the development, production, and distribution of personal care products. The companys extensive portfolio includes face and body care, perfumes, depilation products, makeup, shaving items, deodorants, and hair care solutions. Miraculum operates under a diverse range of brands, including Pani Walewska, Miraculum, Gracja, Tanita, Paloma, Joko, Chopin, Lider, Wars, and Byc Moze, catering to both men and women in Poland and international markets. With nearly a century of experience, the company has built a strong market presence in the personal care sector.

As a key player in the cosmetics industry, Miraculum S.A. focuses on delivering a wide array of products that meet evolving consumer preferences. Its brand portfolio reflects a mix of heritage and innovation, with products tailored to different demographics and preferences. The companys strategic approach includes maintaining a strong distribution network and leveraging its long-standing reputation for quality and affordability.

From a market perspective, Miraculum S.A. operates in a competitive landscape, with its performance influenced by consumer trends, pricing strategies, and regulatory environments. The companys ability to adapt to changing market dynamics, coupled with its established brand equity, positions it as a significant contender in the personal care products sector.

Objective: Miraculum S.A. is a Poland-based cosmetics company with a diverse portfolio of personal care products, operating under multiple brands to serve men and women domestically and internationally. 3-Month Forecast: Based on the provided and , the forecast for Miraculum S.A. (WAR:MIR) is as follows: - Price Movement: The stock is currently trading at 0.82 PLN, slightly below its 20-day SMA (0.84) and 50-day SMA (0.83), but significantly below its 200-day SMA (0.98). This suggests potential sideways movement or minor declines in the near term. - Volatility: The ATR of 0.03 indicates low volatility, suggesting small price fluctuations over the next three months. - Valuation: The P/S ratio of 0.82 and P/B ratio of 1.31 suggest the stock may be undervalued relative to its peers, though the negative RoE (-6.47) raises concerns about profitability. - Market Sentiment: The lack of forward P/E data and negative RoE may weigh on investor sentiment, potentially limiting upside in the short term. Overall, the stock is expected to remain range-bound with a slight bearish bias, driven by weak fundamentals and technical indicators. Investors should monitor the companys financial health and market positioning closely.

Additional Sources for MIR Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MIR Stock Overview

Market Cap in USD 11m
Sector Consumer Defensive
Industry Household & Personal Products
GiC Sub-Industry Personal Care Products
IPO / Inception

MIR Stock Ratings

Growth Rating -55.5
Fundamental 10.8
Dividend Rating 0.0
Rel. Strength -43.1
Analysts -
Fair Price Momentum 0.65 PLN
Fair Price DCF -

MIR Dividends

No Dividends Paid

MIR Growth Ratios

Growth Correlation 3m -76.7%
Growth Correlation 12m -90.2%
Growth Correlation 5y -44.4%
CAGR 5y -9.97%
CAGR/Max DD 5y -0.16
Sharpe Ratio 12m -0.12
Alpha -42.05
Beta 0.426
Volatility 44.24%
Current Volume 0k
Average Volume 20d 8.9k
What is the price of MIR stocks?
As of April 19, 2025, the stock is trading at PLN 0.78 with a total of 10 shares traded.
Over the past week, the price has changed by -4.16%, over one month by -5.31%, over three months by -6.44% and over the past year by -35.21%.
Is Miraculum a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Miraculum is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.80 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MIR as of April 2025 is 0.65. This means that MIR is currently overvalued and has a potential downside of -16.67%.
Is MIR a buy, sell or hold?
Miraculum has no consensus analysts rating.
What are the forecast for MIR stock price target?
According to ValueRays Forecast Model, MIR Miraculum will be worth about 0.7 in April 2026. The stock is currently trading at 0.78. This means that the stock has a potential downside of -10.26%.
Issuer Forecast Upside
Wallstreet Target Price 0.9 9%
Analysts Target Price - -
ValueRay Target Price 0.7 -10.3%